How are adverse effects of therapy managed in patients with cholangiocarcinoma (CCC)?

Updated: Dec 28, 2019
  • Author: Peter E Darwin, MD; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print

Most patients with cholangiocarcinoma require follow-up care for acute and late adverse effects of therapy. Aggressive follow-up care also is necessary to treat symptoms from tumor recurrence and persistence. Patients with the best prognosis may be seen every 2-3 months with periodic laboratory and imaging studies (eg, CT scan).

Patients treated palliatively should enter hospice programs rapidly, as median survival duration is only 2-8 months.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!